Back to Search
CORY OSBORNE, DO
DO
Physical Medicine & Rehabilitation Physician
NPI: 1528592235IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
BP10059366(TX)
Physical Medicine & Rehabilitation PhysicianPrimary
Physical Medicine & Rehabilitation
Code: 208100000X
T2461(TX)
CMS Specialties
PrimaryPHYSICAL MEDICINE AND REHABILITATION
Education
UNIVERSITY OF NORTH TEXAS HSC, COLLEGE OF OSTEOPATHIC MED
Class of 2017
Research & Publications (20)
The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer.
PMID 19139988·Breast Cancer Res Treat·2009
8-other
Endocrine responsiveness: understanding how progesterone receptor can be used to select endocrine therapy.
PMID 16236516·Breast·2005
6-review
Estrogen-receptor biology: continuing progress and therapeutic implications.
PMID 15755967·J Clin Oncol·2005
6-review
The influence of marital status on the stage at diagnosis, treatment, and survival of older women with breast cancer.
PMID 16184457·Breast Cancer Res Treat·2005
8-other
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action.
PMID 15094757·Br J Cancer·2004
6-review
Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancer.
PMID 14659106·Breast·2003
6-review
Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer.
PMID 12618500·J Natl Cancer Inst·2003
8-other
Role of molecular and genetic markers in breast cancer treatment decisions.
PMID 14645413·J Clin Oncol·2003
8-other
Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial.
PMID 12177098·J Clin Oncol·2002
3-trial
Selective estrogen receptor modulators: structure, function, and clinical use.
PMID 10963646·J Clin Oncol·2000
6-review
Low SAFB levels are associated with worse outcome in breast cancer patients.
PMID 19137425·Breast Cancer Res Treat·2010
8-other
Water-use responses of 'living fossil' conifers to CO2 enrichment in a simulated Cretaceous polar environment.
PMID 19447810·Ann Bot·2009
8-other
Efficacy and safety of laser lithotripsy in fragmentation of urocystoliths and urethroliths for removal in dogs.
PMID 19442022·J Am Vet Med Assoc·2009
7-preclinical
Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in mice.
PMID 19141783·J Natl Cancer Inst·2009
7-preclinical
Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897.
PMID 19307504·J Clin Oncol·2009
8-other
Ecological selection pressures for C4 photosynthesis in the grasses.
PMID 19324795·Proc Biol Sci·2009
4-observational
In vivo characterization of the peptide deformylase inhibitor LBM415 in murine infection models.
PMID 19596876·Antimicrob Agents Chemother·2009
7-preclinical
Comparison of laser lithotripsy and cystotomy for the management of dogs with urolithiasis.
PMID 19442023·J Am Vet Med Assoc·2009
4-observational
Arsenite exposure compromises early embryonic development in the Golden hamster.
PMID 19447171·Reprod Toxicol·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7703 FLOYD CURL DR
SAN ANTONIO, TX 78229 - Phone
- (210) 567-5300
Quick Facts
- NPI
- 1528592235
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile